233348 A Rights-Based Approach to Health Care Reform

Tuesday, November 9, 2010 : 2:50 PM - 3:10 PM

Anja Rudiger, PhD , National Economic and Social Rights Initiative, New York, NY
This presentation will analyze the scope and content of a rights-based approach to health care reform in the United States. Tracing the evolution of a health rights discourse in the United States, our research correlates international legal proclamations on the human right to health with U.S. political, legal, and public health thought on the subject of health care reform, reviewing the grounds upon which the right to health can be seen to have evolved in the U.S. health care debate. Based upon this analysis we identify the current stratified, market-based system of health care in the United States as a key barrier to realizing the human right to health. The presentation will focus on illustrating a rights-based approach to health care reform, using the recent federal reform debate and new health reform law as an example. Drawing on international legal standards, our analysis concludes that this latest iteration of federal health care reform has failed to fully meet the human rights principles of universality, equity, and accountability.

Learning Areas:
Provision of health care to the public
Public health or related laws, regulations, standards, or guidelines
Public health or related public policy

Learning Objectives:
By the end of the session participants will be able to: 1. To explain the basic content of the international human right to health framework 2. To apply the human right to health framework to health care reform in the United States 3. To discuss whether a health system meets human rights standards

Keywords: Public Health Policy, Health Care Reform

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: author of chapter on this topic in forthcoming book
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.